Me Newswire / Business Wire
RESEARCH TRIANGLE PARK, N. - Saturday, August 31st 2013
Quintiles CEO Tom Pike and Chief Financial Officer Kevin Gordon will present at the Baird Healthcare Conference on Tuesday, September 10, 2013 in New York, NY at the New York Palace.
The Quintiles presentation will begin at 1:45 p.m. EDT. A link to live audio of the Quintiles presentation will be posted in the Event Calendar of Quintiles’ website, www.quintiles.com/investors. An archived audio version of the presentation will be available later that day.
About Quintiles
Quintiles (NYSE: Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 27,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.
Click here to subscribe to Mobile Alerts for Quintiles.
Contacts
Quintiles
Phil Bridges, Media Relations
+1-919-998-1653
phil.bridges@quintiles.com
Karl Deonanan, Investor Relations
+1-919-998-2789
InvestorRelations@quintiles.com
Permalink: http://www.me-newswire.net/news/8365/en
RESEARCH TRIANGLE PARK, N. - Saturday, August 31st 2013
Quintiles CEO Tom Pike and Chief Financial Officer Kevin Gordon will present at the Baird Healthcare Conference on Tuesday, September 10, 2013 in New York, NY at the New York Palace.
The Quintiles presentation will begin at 1:45 p.m. EDT. A link to live audio of the Quintiles presentation will be posted in the Event Calendar of Quintiles’ website, www.quintiles.com/investors. An archived audio version of the presentation will be available later that day.
About Quintiles
Quintiles (NYSE: Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 27,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.
Click here to subscribe to Mobile Alerts for Quintiles.
Contacts
Quintiles
Phil Bridges, Media Relations
+1-919-998-1653
phil.bridges@quintiles.com
Karl Deonanan, Investor Relations
+1-919-998-2789
InvestorRelations@quintiles.com
Permalink: http://www.me-newswire.net/news/8365/en